Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,234,984
  • Shares Outstanding, K 1,740,600
  • Annual Sales, $ 20,853 M
  • Annual Income, $ 1,400 M
  • 36-Month Beta 1.06
  • Price/Sales 3.97
  • Price/Cash Flow 21.18
  • Price/Book 3.19

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.90 +4.18%
on 12/26/17
59.68 -0.67%
on 01/19/18
+2.35 (+4.13%)
since 12/22/17
3-Month
53.61 +10.58%
on 11/01/17
59.68 -0.67%
on 01/19/18
+2.96 (+5.26%)
since 10/20/17
52-Week
39.25 +51.03%
on 01/25/17
59.68 -0.67%
on 01/19/18
+18.82 (+46.52%)
since 01/20/17

Most Recent Stories

More News
Can Diagnostics Business Drive Abbott's (ABT) Q4 Earnings?

Abbott (ABT) poised to gain on continued growth in Diagnostics business in Q4.

ABT : 59.34 (+0.05%)
HSIC : 76.08 (+0.16%)
MYGN : 39.91 (+3.34%)
BIO : 253.65 (-0.35%)
Can EPD & Medical Devices Drive Abbott's (ABT) Q4 Earnings?

Abbott (ABT) poised to ride high on continued growth in EPD and Medical Devices business in Q4.

ABT : 59.34 (+0.05%)
HSIC : 76.08 (+0.16%)
MYGN : 39.91 (+3.34%)
BIO : 253.65 (-0.35%)
Arterial Stents Market to expand at a healthy 9.5% CAGR by 2025, globally: Transparency Market Research

Arterial stents are key components of percutaneous coronary intervention (PCI) procedures commonly known as angioplasty and makes for a market that is expanding with rising incidence of blockage in the...

ABT : 59.34 (+0.05%)
BSX : 27.57 (-0.29%)
MDT : 85.88 (-0.92%)
Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre

Abbott (ABT) forges ahead with initiatives to boost diabetes care. The latest CMS recognition will widen customer base for FreeStyle Libre glucose monitoring system.

ABT : 59.34 (+0.05%)
JNJ : 147.64 (+0.19%)
BIO : 253.65 (-0.35%)
ISRG : 433.37 (+0.03%)
Namal Nawana Elected to Hologic Board of Directors

Hologic, Inc. (Nasdaq: HOLX) announced today that Namal Nawana has been elected to the Company's Board of Directors, effective immediately.

HOLX : 43.17 (-0.67%)
ABT : 59.34 (+0.05%)
ALR : 50.99 (unch)
JNJ : 147.64 (+0.19%)
Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients

Abbott (NYSE: ABT) today announced that the FreeStyle® Libre System, the company's revolutionary new continuous glucose monitoring (CGM) system, is now available to Medicare patients, having met the codes...

ABT : 59.34 (+0.05%)
Abbott Boosts Diagnostics Arm With Alinity H-Series Launch

Abbott (ABT) adopts initiatives to strengthen hold in the high-potential diagnostics market.

ABT : 59.34 (+0.05%)
DGX : 103.35 (+0.28%)
WBA : 76.59 (+0.16%)
QGEN : 33.09 (+0.67%)
Strong factory data, Wall St gains boost Asian share prices

TOKYO (AP) — Strong manufacturing data and overnight gains on Wall Street gave Asian markets a boost on Wednesday.

TGT : 78.21 (+0.14%)
NVDA : 232.78 (+1.16%)
ABT : 59.34 (+0.05%)
Watch for Abbott Labs to Potentially Pullback After Gaining 3.65% Yesterday

Abbott Labs (NYSE:ABT) traded in a range yesterday that spanned from a low of $57.82 to a high of $59.20. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $57.77...

ABT : 59.34 (+0.05%)
Abbott Launches Alinity(TM) h-series Integrated Hematology System, Combining Speed, Accuracy and Seamless Integration

Abbott (NYSE: ABT) today announced CE Mark for its Alinity h-series integrated system for hematology testing, joining the Alinity hq standalone hematology analyzer, which obtained CE Mark earlier this...

ABT : 59.34 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

2nd Resistance Point 60.04
1st Resistance Point 59.67
Last Price 59.34
1st Support Level 58.95
2nd Support Level 58.60

See More

52-Week High 59.68
Last Price 59.34
Fibonacci 61.8% 51.88
Fibonacci 50% 49.47
Fibonacci 38.2% 47.05
52-Week Low 39.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.